Evidence map›Paper›PMID 31969423›Full record

ArticleJournal of clinical microbiology2020

Tick-Borne Encephalitis Virus Nonstructural Protein 1 IgG Enzyme-Linked Immunosorbent Assay for Differentiating Infection versus Vaccination Antibody Responses.

P Girl, M Bestehorn-Willmann, S Zange, J P Borde, G Dobler, H von Buttlar

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 49 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. New Aspects on Tick-borne Encephalitis in Children.The Pediatric infectious disease journal · 2026
    Article
  8. Article
  9. Tick-Borne Encephalitis in the 21Le infezioni in medicina · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Seroprevalence of tick-borne encephalitis virus and vaccination coverage of tick-borne encephalitis, Sweden, 2018 to 2019.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

P GirlBundeswehr Institute of Microbiology, German National Consultant Laboratory for TBEV, Munich, Germany.
M Bestehorn-WillmannInstitute of Zoology, Parasitology, University of Hohenheim, Stuttgart, Germany.
S ZangeBundeswehr Institute of Microbiology, German National Consultant Laboratory for TBEV, Munich, Germany.
J P BordeDivision of Infectious Diseases, Department of Medicine II, University of Freiburg Medical Center and Faculty of Medicine, Freiburg, Germany.
G DoblerBundeswehr Institute of Microbiology, German National Consultant Laboratory for TBEV, Munich, Germany gerharddobler@bundeswehr.org.
H von ButtlarBundeswehr Institute of Microbiology, German National Consultant Laboratory for TBEV, Munich, Germany.
Institut für Mikrobiologie der BundeswehrUniversität der Bundeswehr München · DEUniversity Medical Center Freiburg · DEUniversity of Hohenheim · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tick-borne encephalitis virus (TBEV) is an important central nervous system (CNS) infection in Europe and Asia. It is a flavivirus in the tick-borne group. Effective vaccines against TBE are available in the affected countries. However, diagnosing TBE is challenging due to cross-reactive antibodies between different viruses of the genus

Indexed as

Encephalitis, Tick-BorneEncephalitis Viruses, Tick-BorneAntibodies, ViralAntibody FormationAsiaEnzyme-Linked Immunosorbent AssayEuropeHumansImmunoglobulin GVaccinationAntibodies, ViralImmunoglobulin GELISAflavivirusNS1 antigentick-borne encephalitis

Identifiers

PMID31969423
PMCPMC7098735
OpenAlexW3002526312

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.